127413-31-4
Chemical Structure
Flecainide-d3
- CAS No.: 127413-31-4
- Formula:C17H17D3F6N2O3
- Molecular Weight:417.36
IUPAC Name: N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide-3,4,6-d3
InChIKey: DJBNUMBKLMJRSA-JZLVSFENSA-N
SMILES: O=C(C1=C(C([2H])=C([2H])C(OCC(F)(F)F)=C1[2H])OCC(F)(F)F)NCC2CCCCN2
Biological Activity: Flecainide-d3 is the deuterium labeled Flecainide. Flecainide is an orally active antiarrhythmic agent. Flecainide can block sodium channels and inhibit calcium ion release mediated by the cardiac ryanodine receptor (RyR2). Flecainide can be used in the research of diseases such as catecholaminergic polymorphic ventricular tachycardia (CPVT)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Flecainide-d3 | 99.9% | Flecainide-d3 is the deuterium labeled Flecainide. Flecainide is an orally active antiarrhythmic agent. Flecainide can block sodium channels and inhibit calcium ion release mediated by the cardiac ryanodine receptor (RyR2). Flecainide can be used in the research of diseases such as catecholaminergic polymorphic ventricular tachycardia (CPVT). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Flecainide (Standard) | ≥98% | Flecainide (Standard) is the analytical standard of Flecainide. This product is intended for research and analytical applications. Flecainide is an orally active antiarrhythmic agent. Flecainide can block sodium channels and inhibit calcium ion release mediated by the cardiac ryanodine receptor (RyR2). Flecainide can be used in the research of diseases such as catecholaminergic polymorphic ventricular tachycardia (CPVT). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Flecainide | 99.98% | Flecainide is an orally active antiarrhythmic agent. Flecainide can block sodium channels and inhibit calcium ion release mediated by the cardiac ryanodine receptor (RyR2). Flecainide can be used in the research of diseases such as catecholaminergic polymorphic ventricular tachycardia (CPVT). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
